πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 429 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9834597

Modified FC polypeptides, FC conjugates, and methods of use thereof

The Regents of the University of California Β· Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9828410

Ξ²-D-2β€²-deoxy-2β€²-Ξ±-fluoro-2β€²-Ξ²-C-substituted-2-modified-N6-substituted purine nucleotides f

Atea Pharmaceuticals, Inc. Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9827202

Hot-melt extrusion of modified release multi-particulates

The Board of Regents of the University of Texas System Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9796974

Modified RNAi agents

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9795655

Modified MT-SP1 proteases that inhibit complement activation

Catalyst Biosciences, Inc. Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9789180

D-amino acid derivative-modified peptidoglycan and methods of use thereof

The Regents of the University of California Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9790499

Functionally-modified oligonucleotides and subunits thereof

Sarepta Therapeutics, Inc. Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9732161

Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates

Sutro Biopharma, Inc. Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9707283

Genetically modified babesia parasites expressing protective tick antigens and uses thereo

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9708386

Modified chimeric polypeptides with improved pharmacokinetic properties

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9708610

Compositions comprising alternating 2β€²-modified nucleosides for use in gene modulation

Ionis Pharmaceuticals, Inc. Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9700025

Genetically modified major histocompatibility complex animals

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9682934

Modified amino acids

Sutro Biopharma, Inc. Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9677052

Modified lipopolysaccharide glycoform and method of use

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9670506

Modified immunization vectors

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9673409

Phosphorescent tetradentate metal complexes having modified emission spectra

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9644039

Acid-degradable and bioerodible modified polyhydroxylated materials

The Regents of the University of California Β· Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9642916

Porphyrin modified telodendrimers

The Regents of the University of California Β· Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9603829

HSP90 inhibitors with modified toxicity

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9554563

Genetically modified mice and engraftment

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9555159

Inorganically surface-modified polymers and methods for making and using them

The Regents of the University of California Β· Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9505826

Modified antibody with improved half-life

TEVA PHARMACEUTICALS AUSTRALIA PTY LTD Β· Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9498544

Genetically modified human umbilical cord perivascular cells for prophylaxis against or tr

Tissue Regeneration Therapeutics Inc. Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9493757

Modified factor VII or factor VIIa polypeptides

Regents of the University of Minnesota Β· Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted